4.4 Article

Plaque Assay for Murine Norovirus

期刊

出版社

JOURNAL OF VISUALIZED EXPERIMENTS
DOI: 10.3791/4297

关键词

Virology; Issue 66; Immunology; Infection; Medicine; Microbiology; Molecular Biology; plaque assay; norovirus; murine norovirus; MNV; murine macrophages; RAW 264.7 cells

资金

  1. University of Michigan
  2. NIH/NIAID Regional Center of Excellence for Bio-defense and Emerging Infectious Diseases Research (RCE) Program
  3. Region V 'Great Lakes' RCE (NIH) [1-U54-AI-057153]
  4. NIH [R01 AI080611]
  5. Experimental Immunology (NIH) [T32 A1007413-16]
  6. Molecular Mechanisms in Microbial Pathogenesis (NIH) [T32 A1007528]
  7. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brasilia, Brazil

向作者/读者索取更多资源

Murine norovirus (MNV) is the only member of the Norovirus genus that efficiently grows in tissue culture (1, 2). Cell lysis and cytopathic effect (CPE) are observed during MNV-1 infection of murine dendritic cells or macrophages (1). This property of MNV-1 can be used to quantify the number of infectious particles in a given sample by performing a plaque assay (1). The plaque assay relies on the ability of MNV-1 to lyse cells and to form holes in a confluent cell monolayer, which are called plaques (3). Multiple techniques can be used to detect viral infections in tissue culture, harvested tissue, clinical, and environmental samples, but not all measure the number of infectious particles (e.g. qRT-PCR). One way to quantify infectious viral particles is to perform a plaque assay (3), which will be described in detail below. A variation on the MNV plaque assay is the fluorescent focus assay, where MNV antigen is immunostained in cell monolayers(4). This assay can be faster, since viral antigen expression precedes plaque formation. It is also useful for titrating viruses unable to form plaques. However, the fluorescent focus assay requires additional resources beyond those of the plaque assay, such as antibodies and a microscope to count focus-forming units. Infectious MNV can also be quantified by determining the 50% Tissue Culture Infective Dose (TCID50) (3). This assay measures the amount of virus required to produce CPE in 50% of inoculated tissue culture cells by endpoint titration (5). However, its limit of detection is higher compared to a plaque assay (4). In this article, we describe a plaque assay protocol that can be used to effectively determine the number of infectious MNV particles present in biological or environmental samples (1, 4, 6). This method is based on the preparation of 10-fold serial dilutions of MNV-containing samples, which are used to inoculate a monolayer of permissive cells (RAW 264.7 murine macrophage cells). Virus is allowed to attach to the cell monolayer for a given period of time and then aspirated before covering cells with a mixture of agarose and cell culture media. The agar enables the spread of viral progeny to neighboring cells while limiting spread to distantly located cells. Consequently, infected cells are lysed and form holes in the monolayer known as plaques. Upon sufficient spread of virus, plaques become visible following staining of cells with dyes, like neutral red, methylene blue, or crystal violet. At low dilutions, each plaque originates from one infectious viral particle and its progeny, which spread to neighboring cells. Thus, counting the number of plaques allows one to calculate plaque-forming units (PFU) present in the undiluted sample(3).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据